What happened to that drug that kills dht receptors in your scalp 10/2/2024
A new therapy aimed at destroying DHT receptors in the scalp is still in early trials and may take at least 5 years to become available. A sugar-like solution similar to Minoxidil is also in early testing stages and not yet commercialized.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity What the hell does it mean by “do not apply to front of scalp”
Minoxidil can be applied to the entire scalp, including the hairline, despite labels suggesting otherwise due to lack of specific testing. For best results in treating hair loss, combining minoxidil with finasteride is recommended, as finasteride addresses the underlying cause of male pattern baldness.
community 5 years post hair transplant, 3 months on minoxidil only
The user had a hair transplant five years ago and started using minoxidil three months ago. Commenters recommend adding finasteride or other DHT blockers to prevent further hair loss and maintain results.
community Creatine's effect on Hair Loss and DHT
A 21-year-old male managed to control his hair loss using Nizoral, RU58841, and finasteride, but experienced increased scalp itchiness after starting creatine, which subsided upon stopping creatine. Users shared mixed experiences on whether creatine affects hair loss, with some reporting negative effects and others seeing no change or defending its benefits.
community The Real Cause Of Androgenetic Alopecia
Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.
community Stopped topical Minox and Fin for 2 years, started again and gained my old status back
A user stopped using finasteride and topical minoxidil for 2 years, saw hair thinning, then restarted the treatments along with weekly dermastamping and regained their previous hair status. The user suggests that restarting treatment can be effective even after a break.
community Sandalore experiment
A user added sandalore to minoxidil for hair loss, observing some vellus hair growth and less scalp inflammation. Others tried sandalore with mixed results, discussing dosage and effectiveness compared to minoxidil and finasteride.
Related Research
6 / 6 resultsresearch The decrease of the Minoxidil 1% side effects by using herbal stimulants in cerita hair tonic
This study found that using Cerita anti hair loss tonic significantly reduced daily hair loss in men compared to a temple lotion, suggesting potential benefits of herbal stimulators in addressing androgenic hair loss.
research Male Pattern Baldness
This review discusses available treatments for androgenetic alopecia in men, like finasteride and 5% minoxidil, and notes that hair growth results are unpredictable and often driven by industry-sponsored studies.
research Cosmeceutical Treatments for Androgenetic Alopecia
This review discusses the genetic and hormonal factors involved in androgenetic alopecia but reports no new research findings.
research Hair aging and anti-aging
This review discusses the biological and cosmetic aspects of hair aging and reports no new clinical results; it highlights current treatments and future research directions to address both aging factors.
research NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY
This review highlights the potential of nanocarriers, like liposomes and solid lipid nanoparticles, in improving targeted drug delivery and effectiveness for androgenetic alopecia treatment, while noting the hurdles of clinical trials and regulatory approval for these advanced methods.
research NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY
This review discusses the potential of nanocarriers like liposomes and nanoparticles to enhance the delivery and efficacy of treatments for androgenetic alopecia, while noting the challenges of clinical translation, such as securing reliable trials and regulatory approval.